cell injury

Cards (17)

  • The components of cellular event inflammation includes understanding of the influx of leukocytes that is neutrophils and monocytes to the site of injury
  • Leukocyte migration from lumen to site of injury
    1. Margination
    2. Rolling
    3. Adhesion
    4. Transmigration
    5. Chemotaxis
  • Margination
    Redistribution of leukocytes along the margins of the blood vessels
  • Rolling
    Transient binding and detachment of leukocytes to endothelial cells
  • Selectins
    • Family of proteins that mediate the rolling phenomenon
    • P-selectin and E-selectin are expressed on activated endothelial cells
    • L-selectin is expressed on leukocytes
  • Adhesion
    Firm binding of leukocytes to endothelial cells mediated by integrins
  • Integrins
    • Transmembrane glycoproteins involved in adhesion
    • Expressed on activated leukocytes
    • Bind to ligands on endothelial cells
  • Transmigration
    Passage of leukocytes through the endothelial cell layer
  • PECAM-1
    • Cellular adhesion molecule that mediates transmigration
    • Also known as CD31
  • Chemotaxis
    Migration of leukocytes towards a chemotactic gradient
  • Chemotactic factors
    • Exogenous (bacterial products)
    • Endogenous (cytokines, complement factors, arachidonic acid metabolites)
  • Neutrophils predominate in the initial stages of acute inflammation, followed by monocytes after 24-48 hours
  • Neutrophils are more numerous, respond more rapidly to chemokines, and adhere more firmly to adhesion molecules compared to other leukocytes
  • Neutrophils are short-lived and undergo apoptosis, while monocytes survive longer and proliferate in tissues to become macrophages
  • There are exceptions, such as Pseudomonas infection where neutrophils continue to be recruited for several days, and viral infections where lymphocytes predominate
  • Understanding the mechanism of leukocyte recruitment provides potential therapeutic targets for controlling harmful inflammation
  • Examples of therapeutic targets include TNF blockers and integrin antagonists